End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,420 KRW | +0.11% | +1.81% | -11.08% |
08/01 | CHA Biotech to Partner with Subsidiary to Advance NK Cell Therapy | MT |
2023 | CHA Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-11.08% | 719M | |
+24.50% | 46.71B | |
+48.83% | 41.8B | |
-1.13% | 41.52B | |
-3.42% | 29.55B | |
+10.33% | 25.78B | |
-20.60% | 19.26B | |
+0.29% | 12.14B | |
-0.22% | 12.08B | |
+26.10% | 11.98B |
- Stock Market
- Equities
- A085660 Stock
- News Chabiotech Co.,Ltd.
- CHA Biotech to Partner with Subsidiary to Advance NK Cell Therapy